Format

Send to

Choose Destination
Lab Chip. 2012 Jun 21;12(12):2211-20. doi: 10.1039/c2lc00001f. Epub 2012 May 15.

A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode C. elegans.

Author information

1
Institute of Neuroscience, University of Oregon, Eugene, OR 97403-1254, USA. shawn@uoregon.edu

Abstract

This paper describes the fabrication and use of a microfluidic device for performing whole-animal chemical screens using non-invasive electrophysiological readouts of neuromuscular function in the nematode worm, C. elegans. The device consists of an array of microchannels to which electrodes are attached to form recording modules capable of detecting the electrical activity of the pharynx, a heart-like neuromuscular organ involved in feeding. The array is coupled to a tree-like arrangement of distribution channels that automatically delivers one nematode to each recording module. The same channels are then used to perfuse the recording modules with test solutions while recording the electropharyngeogram (EPG) from each worm with sufficient sensitivity to detect each pharyngeal contraction. The device accurately reported the acute effects of known anthelmintics (anti-nematode drugs) and also correctly distinguished a specific drug-resistant mutant strain of C. elegans from wild type. The approach described here is readily adaptable to parasitic species for the identification of novel anthelmintics. It is also applicable in toxicology and drug discovery programs for human metabolic and degenerative diseases for which C. elegans is used as a model.

PMID:
22588281
PMCID:
PMC3372093
DOI:
10.1039/c2lc00001f
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Royal Society of Chemistry Icon for PubMed Central
Loading ...
Support Center